“De Novo” pathway- Established by the Food and Drug Administration Modernization Act of 1997 to provide a new mechanism for reclassification of certain lower risk devices from class Ⅲ to class ⅠorⅡ. Examples of De Novos Granted for Devices Presentng…   Read more»